Emerging Therapies for IgA Nephropathy
medcases00
Published on Nov 29, 2022
Atrasentan and BION-1301 - An Interim Analyses from ERA 2022
Dr. Dana Rizk
Professor of Medicine
University of Alabama at Birmingham
Dr. Sreedhar Mandayam
Professor of Medicine
University of Texas
MD Anderson Cancer Center
Dr. Andrew King
Chief Scientific Officer
Chinook Therapeutics
www.glomcon.org
www.edu.glomcon.org
www.pubs.glomcon.org
Category
Tags
- Your Subscription
medcases00 -
Share Video
Add to
Please Sign In or Create Account to use this feature!
Flag Video
Please Sign In or Create Account to use this feature!
Rate video
Please Sign In or Create Account to use this feature!
Rate video
Please Sign In or Create Account to use this feature!
Up next
Autoplay
Autoplay
Recommended
-
01:31:53
KDIGO Management of Hyperkalemia: New Guidance, Emerging Evidence, and Changing Therapies
138 views 1516 days ago -
20:30
Emerging Therapies for Managing Complement 3 Glomerulopathy
92 views 1008 days ago -
01:02:47
The Role of the Complement System in IgA Nephropathy, C3G, & Membranous Nephropathy
103 views 1021 days ago -
48:32
IgA Nephropathy - Fellow's Level Overview of Basic Pathophysiology and Treatment
127 views 1517 days ago -
01:02:15
The Pathogenesis of IgA Nephropathy and Future Treatment Options. ft Dana Rizk, MD
74 views 1053 days ago -
58:12
"Updates in IgA Nephropathy" presented by Natalie Beck, MD
141 views 1034 days ago -
01:08:16
Updates in LN: New Era of Therapies with Dr. Alfred Kim
118 views 1266 days ago